Conclusion
throat
COLD SYMPTOMS, VIRUS, COMMON COLD, RESPIRATORY VIRAL INFECTION
The outcome of this study supporting a shorter duration of the common cold adds to previous findings in a randomized placebo-controlled study on healthy volunteers treated with ColdZyme, in which a lower oropharyngeal virus load and a reduced duration of common cold symptoms were shown following experimental inoculation with rhinovirus-16 [The results of this and prior trials of ColdZyme throat spray encourage further investigation of this route of administration as an intervention point to mitigate the symptom burden of common respiratory viral infections.